Opioid Induced Bowel Dysfunction in Patients Undergoing Cesarean Section
clinical trial
Press Enter · cited answer in seconds
0 sources
Summary
Opioid Induced Bowel Dysfunction in Patients Undergoing Cesarean Section is a clinical trial[1].
Key Facts
- Opioid Induced Bowel Dysfunction in Patients Undergoing Cesarean Section is in the country of Finland[2].
- Opioid Induced Bowel Dysfunction in Patients Undergoing Cesarean Section's instance of is recorded as clinical trial[3].
- Opioid Induced Bowel Dysfunction in Patients Undergoing Cesarean Section's start time is recorded as +2012-10-31T00:00:00Z[4].
- Opioid Induced Bowel Dysfunction in Patients Undergoing Cesarean Section's end time is recorded as +2017-12-31T00:00:00Z[5].
- Opioid Induced Bowel Dysfunction in Patients Undergoing Cesarean Section's main subject is recorded as constipation[6].
- Opioid Induced Bowel Dysfunction in Patients Undergoing Cesarean Section's number of participants is recorded as {'unit': '1', 'amount': '+90'}[7].
- Opioid Induced Bowel Dysfunction in Patients Undergoing Cesarean Section's title is recorded as Opioid Induced Bowel Dysfunction in Patients Undergoing Cesarean Section[8].
- Opioid Induced Bowel Dysfunction in Patients Undergoing Cesarean Section's short name is recorded as oksisektio[9].
- Opioid Induced Bowel Dysfunction in Patients Undergoing Cesarean Section's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+18'}[10].
- Opioid Induced Bowel Dysfunction in Patients Undergoing Cesarean Section's ClinicalTrials.gov ID is recorded as NCT02571881[11].
- Opioid Induced Bowel Dysfunction in Patients Undergoing Cesarean Section's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+45'}[12].
- Opioid Induced Bowel Dysfunction in Patients Undergoing Cesarean Section's research intervention is recorded as oxycodone[13].
- Opioid Induced Bowel Dysfunction in Patients Undergoing Cesarean Section's research intervention is recorded as naloxone[14].
- Opioid Induced Bowel Dysfunction in Patients Undergoing Cesarean Section's clinical trial phase is recorded as phase IV clinical trial[15].
- Opioid Induced Bowel Dysfunction in Patients Undergoing Cesarean Section's research site is recorded as Kuopio University audiovisual center[16].
- Opioid Induced Bowel Dysfunction in Patients Undergoing Cesarean Section's study type is recorded as interventional study[17].